Clearmind Medicine Inc. (NASDAQ:CMND – Get Free Report)’s share price traded up 6.3% on Friday . The company traded as high as $1.60 and last traded at $1.53. 208,423 shares traded hands during mid-day trading, a decline of 54% from the average session volume of 450,170 shares. The stock had previously closed at $1.44.
Clearmind Medicine Stock Performance
The company has a debt-to-equity ratio of 0.01, a current ratio of 1.71 and a quick ratio of 1.71. The stock’s 50-day moving average is $1.40 and its two-hundred day moving average is $1.41.
Clearmind Medicine Company Profile
Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.
Featured Stories
- Five stocks we like better than Clearmind Medicine
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- Using the MarketBeat Dividend Yield Calculator
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Clearmind Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clearmind Medicine and related companies with MarketBeat.com's FREE daily email newsletter.
